Its knockdown in different cancer cell lines, including RMS, leads to a deregulation of miR-183–EGR1–PTEN network by upregulating EGR1 and PTEN mRNA levels, as well as EGR1 protein levels, both of which are tumor suppressive. The gene discussed is EGR1; the disease is cancer.